GB1370904A - Pharmaceutical composition - Google Patents

Pharmaceutical composition

Info

Publication number: GB1370904A
Authority: GB; United Kingdom
Prior art keywords: pharmaceutical composition; pharmaceutical; composition
Prior art date: 1971-01-26
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.): Expired

Application number

GB5865871A

Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)

Astra USA Inc

Original Assignee

Astra Pharmaceutical Products Inc

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1971-01-26

Filing date

1971-12-17

Publication date

1974-10-16

1971-12-17 Application filed by Astra Pharmaceutical Products Inc filed Critical Astra Pharmaceutical Products Inc

1974-10-16 Publication of GB1370904A publication Critical patent/GB1370904A/en

Status Expired legal-status Critical Current

Links

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
- A61K31/52—Purines, e.g. adenine

GB5865871A 1971-01-26 1971-12-17 Pharmaceutical composition Expired GB1370904A (en)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
US10994271A	1971-01-26	1971-01-26

Publications (1)

Publication Number	Publication Date
GB1370904A true GB1370904A (en)	1974-10-16

Family

ID=22330411

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
GB5865871A Expired GB1370904A (en)	1971-01-26	1971-12-17	Pharmaceutical composition

Country Status (18)

Country	Link
AT (2)	AT310939B (en)
AU (1)	AU465875B2 (en)
BE (2)	BE776768A (en)
BR (2)	BR7108429D0 (en)
CA (2)	CA983850A (en)
DD (2)	DD96400A5 (en)
DE (2)	DE2163055A1 (en)
DK (2)	DK130389B (en)
ES (2)	ES398108A1 (en)
FR (2)	FR2123278B1 (en)
GB (1)	GB1370904A (en)
HU (2)	HU162185B (en)
IE (2)	IE35937B1 (en)
LU (1)	LU64664A1 (en)
NL (2)	NL7117404A (en)
NO (2)	NO135892C (en)
SE (2)	SE391286B (en)
ZA (2)	ZA718327B (en)

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US8952152B2 (en)	2009-03-24	2015-02-10	Proteus S.A.	Methods for purifying phycotoxins, pharmaceutical compositions containing purified phycotoxins, and methods of use thereof
US8975281B2 (en)	2013-03-15	2015-03-10	The Children's Medical Center Corporation	Neosaxitoxin combination formulations for prolonged local anesthesia
US9018222B2 (en)	2006-03-27	2015-04-28	Wex Medical Limited	Use of sodium channel blockers for the treatment of neuropathic pain developing as a consequence of chemotherapy

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US4917894A (en) *	1988-06-29	1990-04-17	Beecham Inc.	Rapid-onset long-duration oral anesthetic composition
US6030974A (en) *	1997-04-02	2000-02-29	The Regents Of The University Of California	Method of anesthesia
US6326020B1 (en)	1997-05-16	2001-12-04	Children's Medical Center Corporation	Local anesthetic formulations

1971
- 1971-12-07 SE SE7115654A patent/SE391286B/en unknown
- 1971-12-07 SE SE7115655A patent/SE391127B/en unknown
- 1971-12-10 NO NO4558/71A patent/NO135892C/en unknown
- 1971-12-10 NO NO4557/71A patent/NO135891C/en unknown
- 1971-12-13 ZA ZA718327A patent/ZA718327B/en unknown
- 1971-12-13 ZA ZA718326A patent/ZA718326B/en unknown
- 1971-12-14 DK DK609571AA patent/DK130389B/en unknown
- 1971-12-16 HU HU71AA689A patent/HU162185B/hu unknown
- 1971-12-16 BE BE776768A patent/BE776768A/en unknown
- 1971-12-16 BE BE776769A patent/BE776769A/en unknown
- 1971-12-16 HU HUAA688A patent/HU162347B/hu unknown
- 1971-12-17 DD DD159688A patent/DD96400A5/xx unknown
- 1971-12-17 FR FR7145543A patent/FR2123278B1/fr not_active Expired
- 1971-12-17 NL NL7117404A patent/NL7117404A/xx not_active Application Discontinuation
- 1971-12-17 DD DD159910A patent/DD96144A5/xx unknown
- 1971-12-17 NL NL7117401A patent/NL7117401A/xx unknown
- 1971-12-17 GB GB5865871A patent/GB1370904A/en not_active Expired
- 1971-12-17 AT AT1084971A patent/AT310939B/en not_active IP Right Cessation
- 1971-12-17 DK DK619971A patent/DK131606C/en active
- 1971-12-17 FR FR7145542A patent/FR2123277B1/fr not_active Expired
- 1971-12-17 AT AT1084871A patent/AT310938B/en not_active IP Right Cessation
- 1971-12-17 CA CA130,377A patent/CA983850A/en not_active Expired
- 1971-12-17 CA CA130,378A patent/CA986012A/en not_active Expired
- 1971-12-18 DE DE19712163055 patent/DE2163055A1/en active Pending
- 1971-12-18 DE DE2163054A patent/DE2163054C3/en not_active Expired
- 1971-12-18 ES ES398108A patent/ES398108A1/en not_active Expired
- 1971-12-18 ES ES398109A patent/ES398109A1/en not_active Expired
- 1971-12-20 IE IE1611/71A patent/IE35937B1/en unknown
- 1971-12-20 BR BR8429/71A patent/BR7108429D0/en unknown
- 1971-12-20 IE IE1610/71A patent/IE35910B1/en unknown
- 1971-12-20 AU AU37100/71A patent/AU465875B2/en not_active Expired
- 1971-12-20 BR BR8428/71A patent/BR7108428D0/en unknown
1972
- 1972-01-26 LU LU64664D patent/LU64664A1/xx unknown

Cited By (11)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US9018222B2 (en)	2006-03-27	2015-04-28	Wex Medical Limited	Use of sodium channel blockers for the treatment of neuropathic pain developing as a consequence of chemotherapy
US10149852B2 (en)	2006-03-27	2018-12-11	Wex Pharmaceuticals Inc.	Use of sodium channel blockers for the treatment of neuropathic pain developing as a consequence of chemotherapy
US10624896B2 (en)	2006-03-27	2020-04-21	Wex Medical Limited	Use of sodium channel blockers for the treatment of neuropathic pain developing as a consequence of chemotherapy
US11419873B2 (en)	2006-03-27	2022-08-23	Wex Medical Limited	Use of sodium channel blockers for the treatment of neuropathic pain developing as a consequence of chemotherapy
US8952152B2 (en)	2009-03-24	2015-02-10	Proteus S.A.	Methods for purifying phycotoxins, pharmaceutical compositions containing purified phycotoxins, and methods of use thereof
US8957207B2 (en)	2009-03-24	2015-02-17	Proteus S.A.	Methods for producing phycotoxins
US9249150B2 (en)	2009-03-24	2016-02-02	Proteus S.A.	Methods for purifying phycotoxins, pharmaceutical compositions containing purified phycotoxins, and methods of use thereof
US8975281B2 (en)	2013-03-15	2015-03-10	The Children's Medical Center Corporation	Neosaxitoxin combination formulations for prolonged local anesthesia
US8975268B2 (en)	2013-03-15	2015-03-10	The Children's Medical Center Corporation	Neosaxitoxin combination formulations for prolonged local anesthesia
US10314833B2 (en)	2013-03-15	2019-06-11	The Children's Medical Center Corporation	Neosaxitoxin combination formulations for prolonged local anesthesia
US10881647B2 (en)	2013-03-15	2021-01-05	The Children's Medical Center Corporation	Neosaxitoxin combination formulations for prolonged local anesthesia

Also Published As

Publication number	Publication date
AU465875B2 (en)	1975-10-09
DE2163054A1 (en)	1974-05-02
AU3710171A (en)	1973-06-28
DK130389C (en)	1975-07-14
FR2123278A1 (en)	1972-09-08
CA983850A (en)	1976-02-17
BR7108429D0 (en)	1973-06-14
CA986012A (en)	1976-03-23
ZA718327B (en)	1972-09-27
SE391286B (en)	1977-02-14
NO135891C (en)	1978-05-16
IE35910B1 (en)	1976-06-23
NL7117404A (en)	1972-07-28
DK130389B (en)	1975-02-17
LU64664A1 (en)	1972-08-23
FR2123278B1 (en)	1975-08-01
DD96400A5 (en)	1973-03-20
IE35937L (en)	1972-07-26
BR7108428D0 (en)	1973-06-14
HU162185B (en)	1973-01-29
DE2163055A1 (en)	1972-10-12
AU3710071A (en)	1973-06-28
BE776768A (en)	1972-06-16
BE776769A (en)	1972-06-16
ES398109A1 (en)	1975-03-16
IE35937B1 (en)	1976-07-07
DE2163054C3 (en)	1979-02-01
ZA718326B (en)	1972-09-27
NO135892C (en)	1978-05-16
NL7117401A (en)	1972-07-28
SE391127B (en)	1977-02-07
DE2163054B2 (en)	1978-06-01
NO135892B (en)	1977-03-14
HU162347B (en)	1973-02-28
AT310938B (en)	1973-10-25
IE35910L (en)	1972-07-26
FR2123277A1 (en)	1972-09-08
DD96144A5 (en)	1973-03-12
NO135891B (en)	1977-03-14
ES398108A1 (en)	1975-03-01
AT310939B (en)	1973-10-25
DK131606B (en)	1975-08-11
DK131606C (en)	1976-01-12
FR2123277B1 (en)	1975-06-13

Legal Events

Date	Code	Title	Description
1975-02-26	PS	Patent sealed
1979-07-18	PCNP	Patent ceased through non-payment of renewal fee

Publication	Publication Date	Title
IE36891L (en)	1973-02-24	Coronary-dilating composition
AU5119173A (en)	1974-07-18	Composition
IL39430A (en)	1975-12-31	Slow release pharmaceutical compositions
AU482733B2 (en)	1975-10-16	Pharmaceutical compositions
ZA727741B (en)	1973-12-19	Thermofomable compositions
IE35991L (en)	1972-07-22	Camphor-containing pharmaceutical composition
MY7700080A (en)	1977-12-31	Pharmaceutical compositions
GB1393014A (en)	1975-05-07	Polyurethane-tar compositions
CA974170A (en)	1975-09-09	Pharmaceutical compositions
ZA718327B (en)	1972-09-27	Pharmaceutical composition
ZA713877B (en)	1972-03-29	Pharmaceutical composition
ZA721363B (en)	1972-11-29	Pharmaceutical composition
GB1367202A (en)	1974-09-18	Reflex-reflecting compositions
ZA721169B (en)	1972-11-29	Pharmaceutical preparation
CY755A (en)	1974-09-10	Therapeutic composition
ZA723908B (en)	1973-03-28	Desensitizer composition
IL39516A (en)	1975-05-22	Substituted 4-propoxy-9-fluorenone compounds and pharmaceutical compositions containing them
CA884857A (en)	1971-11-02	Pharmaceutical composition
CA885421A (en)	1971-11-09	Pharmaceutical composition
CA879074A (en)	1971-08-24	Pharmaceutical compositions
CA888155A (en)	1971-12-14	Pharmaceutical compositions
CA888688A (en)	1971-12-21	Pharmaceutical compositions
CA876689A (en)	1971-07-27	Pharmaceutical compositions
CA884860A (en)	1971-11-02	Pharmaceutical compositions
CA881476A (en)	1971-09-21	Pharmaceutical compositions